BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 23197570)

  • 41. FGF21 promotes metabolic homeostasis via white adipose and leptin in mice.
    Véniant MM; Hale C; Helmering J; Chen MM; Stanislaus S; Busby J; Vonderfecht S; Xu J; Lloyd DJ
    PLoS One; 2012; 7(7):e40164. PubMed ID: 22792234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BetaKlotho is required for metabolic activity of fibroblast growth factor 21.
    Ogawa Y; Kurosu H; Yamamoto M; Nandi A; Rosenblatt KP; Goetz R; Eliseenkova AV; Mohammadi M; Kuro-o M
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7432-7. PubMed ID: 17452648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel approach to improve the function of FGF21.
    Smith R; Duguay A; Weiszmann J; Stanislaus S; Belouski E; Cai L; Yie J; Xu J; Gupte J; Wu X; Li Y
    BioDrugs; 2013 Apr; 27(2):159-66. PubMed ID: 23456652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of metformin on fibroblast growth factor 19, 21 and fibroblast growth factor receptor 1 in high-fat diet and streptozotocin induced diabetic rats.
    Wang Y; Dang N; Sun P; Xia J; Zhang C; Pang S
    Endocr J; 2017 May; 64(5):543-552. PubMed ID: 28413172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms.
    BonDurant LD; Ameka M; Naber MC; Markan KR; Idiga SO; Acevedo MR; Walsh SA; Ornitz DM; Potthoff MJ
    Cell Metab; 2017 Apr; 25(4):935-944.e4. PubMed ID: 28380381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
    Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
    Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
    Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
    Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
    Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
    Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different roles of N- and C- termini in the functional activity of FGF21.
    Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A
    J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action.
    Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y
    EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.
    Owen BM; Mangelsdorf DJ; Kliewer SA
    Trends Endocrinol Metab; 2015 Jan; 26(1):22-9. PubMed ID: 25476453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys.
    Véniant MM; Komorowski R; Chen P; Stanislaus S; Winters K; Hager T; Zhou L; Wada R; Hecht R; Xu J
    Endocrinology; 2012 Sep; 153(9):4192-203. PubMed ID: 22798348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.
    Fisher FM; Chui PC; Antonellis PJ; Bina HA; Kharitonenkov A; Flier JS; Maratos-Flier E
    Diabetes; 2010 Nov; 59(11):2781-9. PubMed ID: 20682689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys.
    Sun HD; Malabunga M; Tonra JR; DiRenzo R; Carrick FE; Zheng H; Berthoud HR; McGuinness OP; Shen J; Bohlen P; Leibel RL; Kussie P
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E964-76. PubMed ID: 17132826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and Monkeys.
    Okamoto H; Kim J; Aglione J; Lee J; Cavino K; Na E; Rafique A; Kim JH; Harp J; Valenzuela DM; Yancopoulos GD; Murphy AJ; Gromada J
    Endocrinology; 2015 Aug; 156(8):2781-94. PubMed ID: 26020795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction.
    Diener JL; Mowbray S; Huang WJ; Yowe D; Xu J; Caplan S; Misra A; Kapur A; Shapiro J; Ke X; Wu X; Bose A; Panza D; Chen M; Beaulieu V; Gao J
    Endocrinology; 2021 Sep; 162(9):. PubMed ID: 33951176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.